Company Info

Krystal Biotech

Drug Discovery & Development

Overview

Krystal Biotech, Inc. (NASDAQ:KRYS) is a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases.

Contributions

Contributors

Contributions

1 Contributions1 / 1

Clinical Trials

Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial and Receives Regenerative Medicine Advanced Therapy Designation

Krystal Biotech

PR-M06-19-NI-047Jun 25, 2019

1 / 1

0 Contributors1 / 0

No authors found

1 / 0